-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CaSn850nMRJDU65h24XFMqZe6mzuiTnzWWNl9uvuLSU1LdvtlhRe6z3wz+on9VNP irgPm6j84Tk6kIGnBUIZ3w== 0001179110-05-013631.txt : 20050705 0001179110-05-013631.hdr.sgml : 20050704 20050705131854 ACCESSION NUMBER: 0001179110-05-013631 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050701 FILED AS OF DATE: 20050705 DATE AS OF CHANGE: 20050705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEORX CORP CENTRAL INDEX KEY: 0000755806 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 911261311 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 BUSINESS PHONE: 2062817001 MAIL ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KARLIN DAVID A CENTRAL INDEX KEY: 0001247409 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16614 FILM NUMBER: 05935793 BUSINESS ADDRESS: BUSINESS PHONE: 6506162200 MAIL ADDRESS: STREET 1: C/O CELLEGY PHARMACEUTICALS INC STREET 2: 349 OYSTER POINT BLVD #200 CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 3 1 edgar.xml FORM 3 - X0202 3 2005-07-01 0 0000755806 NEORX CORP NERX 0001247409 KARLIN DAVID A 300 ELLIOTT AVE. WEST STE. 500 SEATTLE WA 98119-4114 0 1 0 0 Sr. VP, Clinical Devlpt & Reg NeoRx Common Stock 0 D /s/ Mike Jackson 2005-06-30 -----END PRIVACY-ENHANCED MESSAGE-----